Barry Katzen

Barry T. Katzen,M.D. is the founder and chief medical executive emeritus of the Miami Cardiac & Vascular Institute, a system-wide center of excellence that is part of Baptist Health South Florida, the largest health system in South Florida. He is Chairman, Department of Interventional Radiology and professor of radiology and surgery, Herbert Wertheim College of Medicine, Florida International University; and holder of similar appointments at University of Miami, School of Medicine and University of South Florida, Morsani College of Medicine. Since its founding in 1987, the Miami Cardiac & Vascular Institute has served as a national model of success in multidisciplinary cooperation, and is one of the nation’s leading cardiac and vascular institutions.

He established the interventional radiology program, cardiac catheterization laboratory and noninvasive vascular laboratory at Alexandria Hospital in Virginia in 1976, where he pioneered the use of sophisticated video and audio technology to enhance the process of education for practitioners. He is credited with being the first to use “live patient demonstrations” in the United States, which became the benchmark for procedural education in endovascular therapy and many other procedural areas of medicine. Dr. Katzen is one of the pioneers of percutaneous transluminal angioplasty and peripheral thrombolysis for less invasive treatment of vascular disease and was part of the investigative team that lead to the approval of the first intravascular stent.He is one of the founders of interventional radiology as a specialty of medicine, performing the first renal angioplasty in the United States.

Dr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering (by courtesy) at Stanford. Presently, Dr. Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 175 clinical trials, published over 550 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program.
Dr. Fitzgerald has been principle/founder of twenty-one medical device companies in the San Francisco Bay Area. He has transitioned fourteen of these start-ups to large medical device companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Peter was on the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco. In 2009, he co-founded TriVentures, which is an incubator/venture fund for early stage medical technology in Israel.

Mark E. Coticchia is Corporate Vice President, Innovation at Baptist Health South Florida where he is responsible for providing system-wide vision, energy and leadership to technology management, corporate development, new ventures, and commercialization at the largest not-for-profit healthcare organization in South Florida.

Previously, he served as Vice President and Chief Innovation Officer of the Henry Ford Health System in Detroit, Michigan where he led a business unit dedicated to solving complex problems in healthcare and positioned Henry Ford to shape the rapidly changing future of medicine.

With more than thirty years of institutional venture development and technology-based economic development experience, Mr. Coticchia has also served as Vice President for Research, Technology Management, and Economic Development at Case Western Reserve University and Director of Technology Transfer and Adjunct Professor of Entrepreneurship at Carnegie Mellon University. His venture development experiences include CEO of Redwind Innovations LLC, and Senior Director of Redleaf Group Inc., a venture capital firm.

Mr. Coticchia has been an instrumental part of the nationally recognized technology-based ecosystems in Pittsburgh, Cleveland, Detroit, and Miami. He has also served as Advisor to both the United Nations (WIPO) and the U.S. State Department; and Senior Advisor to the Ohio Department of Higher Education, as well as member of the board of directors and advisory boards of many high-tech companies and not-for-profit organizations.

Mr. Coticchia received both his M.S. degree in Industrial Engineering and B.S. degree in Civil Engineering from the University of Pittsburgh. He is an author and speaker at events worldwide.

Barry T. Katzen,M.D. is the founder and chief medical executive emeritus of the Miami Cardiac & Vascular Institute, a system-wide center of excellence that is part of Baptist Health South Florida, the largest health system in South Florida. He is Chairman, Department of Interventional Radiology and professor of radiology and surgery, Herbert Wertheim College of Medicine, Florida International University; and holder of similar appointments at University of Miami, School of Medicine and University of South Florida, Morsani College of Medicine. Since its founding in 1987, the Miami Cardiac & Vascular Institute has served as a national model of success in multidisciplinary cooperation, and is one of the nation’s leading cardiac and vascular institutions.

He established the interventional radiology program, cardiac catheterization laboratory and noninvasive vascular laboratory at Alexandria Hospital in Virginia in 1976, where he pioneered the use of sophisticated video and audio technology to enhance the process of education for practitioners. He is credited with being the first to use “live patient demonstrations” in the United States, which became the benchmark for procedural education in endovascular therapy and many other procedural areas of medicine. Dr. Katzen is one of the pioneers of percutaneous transluminal angioplasty and peripheral thrombolysis for less invasive treatment of vascular disease and was part of the investigative team that lead to the approval of the first intravascular stent.He is one of the founders of interventional radiology as a specialty of medicine, performing the first renal angioplasty in the United States.

An internationally recognized expert in vascular and interventional radiology, Brian Funaki, MD, is currently the Chief of Vascular and Interventional Radiology at the Unversity of Chicago and Co-Editor-in-Chief of the Journal of Vascular and Interventional Radiology. He has more than 200 publications listed in the U.S. National Library of Medicine on a broad range of vascular and non-vascular image-guided interventions. Throughout his career, Dr. Funaki has led many scientific and academic committees. He serves on the Executive Council of the Society of Interventional Radiology. An avid writer, he has authored two books and 11 book chapters. He is frequently invited to contribute articles and editorials for scientific journals, and has presented over 300 invited lectures at universities and national and international medical meetings. He served as editor-in-chief for Seminars in Interventional Radiology from 2004-2011 and is the co-editor in chief of Updates in Interventional Radiology. He has earned many awards and distinctions, including being listed as one of Castle and Connolly’s Top Doctors, "Best Doctors in America" by Best Doctors Inc. and Chicago’s Top Docs in Chicago Magazine.